
Formosa Pharmaceuticals Partners with Cipla to Launch APP13007 in 11 Countries
Formosa Pharmaceuticals has signed an exclusive licensing agreement with Cipla for the commercialization of APP13007, a steroid eye drop approved for treating inflammation and pain after ocular surgery. The deal grants Cipla rights across 11 countries and …